Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.
Black A, Becker W. Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al. Journal Of Addiction Medicine 2025 PMID: 40066875, PMCID: PMC12210154, DOI: 10.1097/adm.0000000000001452.Peer-Reviewed Original ResearchOpioid use disorderUse disorderOral health problemsOral health risksPartial mu-opioid receptor agonistBuprenorphine exposureLong-acting injectable buprenorphineMu-opioid receptor agonistDrug AdministrationImprove withdrawal symptomsOral disease developmentOral hygiene practicesGold standard treatmentWithdrawal symptomsDecreasing opioid-related mortalityFood and Drug AdministrationBuprenorphine administrationTransmucosal formulationsOral diseasesReceptor agonistsIntravenous buprenorphineTooth decayAddiction medicineStandard treatmentHealth problems
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply